As of November 10, 2026, 32 of the 147 tracked funds had filed a Form 13F for the quarter ended September 30, 2026, and all 32 of their Q3 information tables are now parsed in the site’s working data. This article compares each holding with the same fund’s Q2 2026 filing on a CUSIP basis, using the pipeline’s Q2 filings as the baseline. Together the 32 funds reported 2,706 information-table rows as filed, worth about $391.60 billion combined — the total after correcting one fund’s filing scale (see Sources and method). The table below aggregates those rows by (CUSIP, put/call) into 2,642 analysis rows; the two counts describe the same filings on different bases, and the difference is reconciled in Sources and method below. Nothing here is estimated: any fund whose Q3 table could not be parsed would have been left out of the table rather than filled in, and in this batch none had to be.
Form 13F reports long positions only, and it arrives up to 45 days after quarter-end. The deadline for the quarter ended September 30, 2026 is Monday, November 16, 2026: the 45th day falls on Saturday, November 14, 2026, and the filing deadline moves to the next business day. Nothing in this article is a recommendation to buy or sell any security. Positions are reported as filed; a fund's filing is a snapshot at quarter-end, not a record of trades during the quarter, and a position that appears or disappears between two snapshots may reflect a trade, a corporate action, a CUSIP change, or a reclassification.
How to read the table
Counts are computed by CUSIP, not by ticker, against each fund's Q2 2026 filing as held in the site's pipeline data. That choice matters. When an issuer changes its CUSIP between quarters, the old CUSIP disappears and a new CUSIP appears, so a CUSIP-based count records one exit and one new position even though the underlying company may be unchanged. The clearest example in this batch is Exxon Mobil: several funds show a new Exxon CUSIP row and an exited Exxon CUSIP row in the same quarter. The table's "largest new" and "largest exited" columns therefore use a stricter ticker test: they show only tickers that were entirely absent in the other quarter. A ticker that appears on both sides of a CUSIP change is not presented as a new buy or a full exit. In this batch the Exxon CUSIP change appears at all nine funds that hold the stock. Added up without the offsetting exits it would look like $1.1 billion of new buying; netted across the nine funds, the Exxon position grew by about $21.9 million in value while the share count fell by about 1.1 million shares, so no aggregate Exxon buying figure is stated in this article. One more case to watch: a Novartis CUSIP pair at Tweedy Browne differs only by letter case (66987V109 against 66987v109) and is the same position, not a buy and a sale. Shares and values are as filed. Values in the table are the summed values of the parsed Q3 rows for each fund; they are not the funds' total assets, and 13F totals exclude short positions, most derivatives, and non-U.S. holdings that are not reportable on the form.
One baseline note, stated plainly because it changes some counts versus an earlier draft of this article: the Q2 baseline here is the pipeline's Q2 filing for each fund, which carries CUSIP aliases and split adjustments through from the site's own fund pages. A comparison against raw Q2 information tables would give slightly different new-position counts at a few funds (Matrix and Torray among them), because the pipeline baseline already contains some rows that a raw table would show as new. The counts below are the ones consistent with the site's fund pages, and the method is the same for all 32 funds.
What the early filings show
Trimming was more common than adding in this batch. At 23 of the 32 funds, the number of trimmed positions exceeded both the number of added positions and the number of new CUSIP rows. The largest fund in the table by count, Pzena Investment Management, trimmed 90 CUSIP rows and added to 51, while opening 10 new CUSIP rows and exiting 12. Flossbach von Storch trimmed 53 and added to 28. Mondrian Investment Partners opened 35 new CUSIP rows, but only a few of its tickers were genuinely new to its portfolio, led by Haleon at about $158.7 million, and it trimmed 67 rows. Guinness Asset Management opened 46 new CUSIP rows, more than any other fund in the batch, while adding to 94 rows and trimming 42. Activity is not the same as conviction: a trim can be a small percentage reduction, and the table does not show position sizes for trimmed rows, only counts.
The largest genuinely new ticker positions in the batch were concentrated in a small set of names. First Eagle Investment Management opened NVR at about $400.1 million, the largest first-time position in the batch. Davis Advisors opened Zoetis at about $249.3 million and Expand Energy at about $172.1 million. Egerton Capital opened Intercontinental Exchange at about $223.1 million and Meta Platforms at about $139.9 million. Sarasin & Partners opened Applied Materials at about $219.1 million and Illinois Tool Works at about $120.3 million. Alphinity Investment Management opened CSX at about $172.9 million, Entergy at about $134.9 million, and Monster Beverage at about $126.0 million. PineStone Asset Management opened Broadcom at about $126.8 million. Sustainable Growth Advisers opened Quanta Services at about $117.1 million. Mirova US opened Bank of America at about $110.6 million. These are the largest first-time ticker appearances by reported value in the parsed Q3 tables; they are facts about filings, not judgments about the companies.
Full exits were fewer and smaller than the new entries in most cases, with one very large exception. Sanders Capital, the largest fund in the batch at $103.18 billion, exited Procter & Gamble, a prior-quarter position of about $975.0 million, while opening only one new CUSIP row (a $0.2 million Lloyds Banking Group position) and trimming 29 rows. The next largest genuine exits by prior-quarter position were C.H. Robinson at First Eagle Investment Management (about $686.0 million), Accenture at Greenhaven Associates (about $421.2 million), Applied Materials at Egerton Capital (about $376.7 million), and Expeditors International at First Eagle Investment Management (about $329.4 million). One pattern deserves a warning rather than a headline: Nike appears as a genuine exit at three funds in this batch (Matrix, Sarasin, and Sustainable Growth Advisers), and none of the seven funds that filed on November 10 exited it. Three funds exiting the same name in the same quarter is a fact about these filings; it is not evidence about the company, and this article draws no conclusion from it. Markel Group is the exception to the trimming pattern: it held 93 of its CUSIP rows unchanged, added to 27, trimmed only 8, and exited 2, which makes its Q3 filing the quietest large filing in the batch. At the other end, Lindsell Train opened no new CUSIP row and exited none: its 28 rows split into 2 adds, 17 trims, and 9 unchanged. Yacktman Asset Management likewise exited nothing and opened a single new CUSIP row, a $0.9 million Magnum Ice Cream position.
First Eagle Investment Management, the second-largest fund in the table at $63.66 billion, filed the most active table among the November 10 filers: 39 new CUSIP rows, 247 adds, 114 trims, and 44 exits. Two of its largest apparent moves are not moves at all. Its new ONEOK row (about $1.01 billion) and its exited ONEOK row (about $1.03 billion) are the same position under a new CUSIP, with shares essentially unchanged (11,834,827 to 11,838,297); the same is true of its Exxon Mobil rows (about $828 million on each side). The table’s ticker test keeps both out of the largest-new and largest-exited columns, so First Eagle’s largest genuine new position is NVR at $400.1 million and its largest genuine exit is C.H. Robinson at $686.0 million. Davis Advisors opened Zoetis and Expand Energy (above) while exiting two small positions, AvalonBay Communities at about $11.3 million and Darling Ingredients at about $9.3 million. Atalanta Sosnoff opened 27 new CUSIP rows, led by Snowflake at $59.9 million and Regeneron at $57.5 million, and trimmed 73 rows; its Exxon row is a CUSIP replacement, not a new buy. Jensen Investment Management trimmed 63 of its 85 rows and opened four new positions, led by Intuitive Surgical at $40.4 million and American Express at $33.3 million, while exiting Fair Isaac at about $0.9 million and Home Depot at about $0.3 million. Vulcan Value Partners opened two new positions, Skyworks Solutions at $17.3 million and Tyler Technologies at $11.7 million, and exited four, the largest IQVIA at $50.2 million. Muhlenkamp opened six new positions, led by Gartner at $14.4 million; its Exxon row is also a CUSIP replacement. Aquamarine Capital filed the quietest table in the batch: all seven positions unchanged, with no new rows, no exits, no adds, and no trims.
The funds that filed between November 4 and 6 add one more pattern. Mirova US opened Bank of America at $110.6 million while trimming 39 of its 45 rows. Guinness Asset Management opened 46 new CUSIP rows (above), the most of any fund in the batch. Sound Shore opened IQVIA Holdings at $91.1 million — the same name Vulcan Value Partners exited — while Tweedy Browne opened Aptiv at $16.2 million, Check Capital Management opened a single new position in Zoetis at $2.7 million, Veritas Asset Management opened ResMed at $23.9 million, and W.H. Reaves & Co. opened Ciena at $21.0 million.
Main table: 32 early filers with parsed Q3 tables
Counts are CUSIP-based versus Q2 2026. "Largest new" and "largest exited" use the stricter ticker test described above. Accession numbers are SEC filing identifiers; each opens the fund's own filing on EDGAR.
| Fund | Q3 accession | Filed | Q3 analysis rows | Q3 value | New / added | Trimmed / exited | Largest new ticker | Largest exited ticker |
|---|---|---|---|---|---|---|---|---|
| Sanders Capital | 0001172661-26-004809 | 2026-11-02 | 46 | $103.18B | 1 / 16 | 29 / 2 | LYG (LLOYDS BANKING GROUP PLC, $0.2M) | PG (PROCTER & GAMBLE CO) |
| First Eagle Investment Management | 0001325447-26-000037 | 2026-11-10 | 420 | $63.66B | 39 / 247 | 114 / 44 | NVR (NVR INC, $400.1M) | CHRW (C H ROBINSON WORLDWIDE IN) |
| Pzena Investment Management | 0001027796-26-000065 | 2026-10-30 | 159 | $34.10B | 10 / 51 | 90 / 12 | GEHC (GE HEALTHCARE TECHNOLOGIES I, $82.1M) | CSCO (CISCO SYS INC) |
| Davis Advisors | 0001036325-26-000041 | 2026-11-10 | 117 | $23.15B | 7 / 50 | 53 / 2 | ZTS (Zoetis Inc., $249.3M) | DAR (Darling Ingredients Inc.) |
| Flossbach von Storch | 0001575677-26-000011 | 2026-10-28 | 97 | $19.67B | 7 / 28 | 53 / 16 | GGG (GRACO, $27.9M) | MKTX (MARKETAXESS) |
| PineStone Asset Management | 0001172661-26-004579 | 2026-10-16 | 43 | $15.36B | 1 / 9 | 30 / 2 | AVGO (BROADCOM INC, $126.8M) | FND (FLOOR & DECOR HLDGS INC) |
| Markel Group | 0001096343-26-000085 | 2026-10-30 | 145 | $12.84B | 17 / 27 | 8 / 2 | ZBRA (ZEBRA TECHNOLOGIES CORPORATI, $2.4M) | BRO (BROWN & BROWN INC) |
| Sustainable Growth Advisers | 0001290668-26-000005 | 2026-10-15 | 49 | $9.95B | 3 / 5 | 39 / 1 | PWR (Quanta Services Inc, $117.1M) | NKE (NIKE Inc) |
| Egerton Capital | 0001581811-26-000009 | 2026-10-20 | 23 | $9.82B | 4 / 9 | 10 / 4 | ICE (INTERCONTINENTAL EXCHANGE IN, $223.1M) | AMAT (APPLIED MATLS INC) |
| Mirova US | 0001172661-26-004865 | 2026-11-05 | 45 | $9.15B | 2 / 4 | 39 / 2 | BAC (BANK OF AMER CORP, $110.6M) | AWK (AMERICAN WTR WKS CO INC NEW) |
| Sarasin & Partners | 0001510481-26-000005 | 2026-10-13 | 111 | $8.93B | 19 / 32 | 52 / 2 | AMAT (APPLIED MATLS INC, $219.1M) | GGG (GRACO INC) |
| Yacktman Asset Management | 0000905567-26-000005 | 2026-11-02 | 75 | $8.38B | 1 / 42 | 21 / 0 | MICC (Magnum Ice Cream Co. N.V., $0.9M) | — |
| Greenhaven Associates | 0001213900-26-112422 | 2026-10-26 | 27 | $7.96B | 1 / 8 | 14 / 2 | BBWI (Bath & Body Works Inc (BBWI), $0.2M) | ACN (Accenture Plc (ACN)) |
| ACR Alpine Capital Research | 0001508822-26-000008 | 2026-11-02 | 40 | $7.35B | 4 / 25 | 9 / 2 | BRC (BRADY CORP, $5.5M) | FDXF (FEDEX FGHT HLDG CO INC) |
| Guinness Asset Management | 0001409661-26-000008 | 2026-11-05 | 185 | $6.21B | 46 / 94 | 42 / 2 | TEL (TE CONNECTIVITY PLC, $20.7M) | CPRT (COPART INC) |
| Montrusco Bolton Investments | 0001475940-26-000009 | 2026-10-13 | 85 | $5.77B | 11 / 14 | 58 / 6 | VRTX (VERTEX PHARMACEUTICALS INC, $78.4M) | BLK (BLACKROCK INC) |
| W.H. Reaves & Co. | 0000740913-26-000010 | 2026-11-06 | 89 | $5.54B | 6 / 26 | 42 / 11 | CIEN (CIENA CORP COM, $21.0M) | MPC (MARATHON PETROLEUM CORP) |
| Atalanta Sosnoff Capital | 0001172661-26-004921 | 2026-11-10 | 131 | $5.51B | 27 / 27 | 73 / 8 | SNOW (SNOWFLAKE INC, $59.9M) | VRT (VERTIV HOLDINGS CO) |
| Mondrian Investment Partners | 0001317724-26-000013 | 2026-10-23 | 136 | $5.39B | 35 / 25 | 67 / 10 | HLN (Haleon ADR, $158.7M) | CSX (CSX Corp) |
| Veritas Asset Management | 0001172661-26-004858 | 2026-11-05 | 22 | $5.37B | 2 / 5 | 11 / 1 | RMD (RESMED INC, $23.9M) | ELV (ELEVANCE HEALTH INC FORMERLY) |
| Alphinity Investment Management | 0001172661-26-004786 | 2026-11-02 | 31 | $4.51B | 7 / 2 | 22 / 3 | CSX (CSX CORP, $172.9M) | COST (COSTCO WHOLESALE CORPORATION) |
| Check Capital Management | 0001032814-26-000009 | 2026-11-05 | 18 | $3.70B | 1 / 5 | 11 / 0 | ZTS (Zoetis, $2.7M) | — |
| Sound Shore | 0001193125-26-451148 | 2026-11-06 | 40 | $3.20B | 6 / 10 | 23 / 6 | IQV (IQVIA Holdings Inc., $91.1M) | TEVA (Teva Pharmaceutical Industries Ltd. - ADR) |
| Jensen Investment Management | 0001171200-26-000023 | 2026-11-10 | 85 | $3.19B | 4 / 8 | 63 / 2 | ISRG (Intuitive Surgical Inc., $40.4M) | FICO (Fair Isaac Corporation) |
| Vulcan Value Partners | 0001556785-26-000022 | 2026-11-10 | 34 | $3.13B | 2 / 5 | 27 / 4 | SWKS (SKYWORKS SOLUTIONS INC, $17.3M) | IQV (IQVIA HLDGS INC) |
| Lindsell Train | 0001172661-26-004793 | 2026-11-02 | 28 | $2.36B | 0 / 2 | 17 / 0 | — | — |
| Tweedy Browne | 0000732905-26-000001 | 2026-11-04 | 98 | $1.23B | 13 / 47 | 32 / 6 | APTV (APTIV PLC, $16.2M) | KT (KT CORP - ADR) |
| Matrix Asset Advisors | 0001172661-26-004502 | 2026-10-13 | 100 | $1.21B | 2 / 38 | 40 / 8 | UBER (UBER TECHNOLOGIES INC, $11.2M) | LMT (LOCKHEED MARTIN CORP) |
| Torray Funds | 0001193125-26-439683 | 2026-10-30 | 92 | $757.8M | 7 / 23 | 39 / 6 | SPOT (Spotify Technology Sa, $5.2M) | OKE (ONEOK) |
| Investment Management Associates | 0000052024-26-000005 | 2026-10-29 | 32 | $490.4M | 5 / 12 | 11 / 4 | GLD (SPDR GOLD TR, $23.2M) | SOLV (SOLVENTUM CORP) |
| Muhlenkamp | 0001133219-26-000005 | 2026-11-10 | 32 | $410.7M | 6 / 21 | 1 / 2 | IT (GARTNER INC, $14.4M) | TMHC (TAYLOR MORRISON HOME CORP) |
| Aquamarine Capital | 0001953324-26-000004 | 2026-11-10 | 7 | $144.3M | 0 / 0 | 0 / 0 | — | — |
What is still missing
Three gaps remain open, and each is stated rather than papered over. First, CUSIP changes inside the table are flagged only through the ticker test in the last two columns; the count columns themselves still contain CUSIP-change pairs, so they should not be quoted as counts of distinct companies bought or sold. Second, the Q3 filing season is incomplete: 115 of the 147 tracked funds had not filed as of November 10, 2026, and the pattern among early filers need not resemble the pattern among later filers. Early filers are, by definition, the funds that filed first. Third, the row counts use two stated bases and must not be mixed. The figure 2,706 is the count of raw information-table rows exactly as filed across the 32 filings. The figure 2,642 is the count of (CUSIP, put/call)-aggregated rows used in this article’s table. The difference is exactly 64 rows, all at two funds: ACR Alpine Capital Research filed 73 raw rows that aggregate to 40 (33 duplicate rows are other-manager split rows for the same CUSIPs), and Alphinity Investment Management filed 62 raw rows that aggregate to 31 (every CUSIP appears twice). The other 30 funds have identical counts on both bases, and the combined value is $391.60 billion on either basis after the Aquamarine scale correction ($391.46 billion on the pipeline’s as-filed figures), because aggregation sums the split rows’ values rather than dropping them.
See also
The Q3 2026 13F tracker follows every tracked fund's filing for the quarter ended September 30, 2026. The companion Q3 deadline post lists the first 18 filings with raw information-table row counts. For how to read any 13F filing, see How to Read a 13F Filing.
Sources and method
Sources: SEC EDGAR Form 13F filings listed by accession number in the table; each fund’s Q3 information table was parsed from its EDGAR original and cross-checked against the filing’s cover total; the Q2 baseline is each fund’s Q2 2026 filing as held in the site’s Q2 2026 holdings data, keyed by Q2 accession; filing dates and accession numbers are from EDGAR submissions data as recorded in the site’s Q3 2026 collection snapshot (last run November 11, 2026, 08:40 KST). Counts are computed by CUSIP against each fund’s Q2 2026 filing, aggregating rows by (CUSIP, put/call); a position counts as added or trimmed only when its share count changed, so value-only moves are price effects. The ‘largest new’ and ‘largest exited’ columns use a stricter test: they show only tickers entirely absent in the other quarter, with an additional issuer-name guard for CUSIP changes whose new CUSIP is unmapped (First Eagle’s ONEOK: old CUSIP 682680103 exited, new CUSIP 30609A109 entered, shares 11,834,827 to 11,838,297, so it is not presented as an exit). One new CUSIP (98978v103, Zoetis) is shown as ZTS; it differs from the mapped CUSIP 98978V103 only by letter case. Q3 values are sums of parsed information-table rows. Row-count criterion: this article’s table counts (CUSIP, put/call)-aggregated rows (2,642 across 32 funds); raw information-table rows as filed total 2,706, the gap of 64 rows sitting entirely in the first 18 funds (ACR Alpine Capital Research, 73 raw to 40 aggregated, and Alphinity Investment Management, 62 raw to 31 aggregated). One correction to the pipeline figures: Aquamarine Capital’s values are filed in thousands, not dollars, so its Q3 total is about $144.26 million, not $144 thousand, and the corrected 32-fund total is about $391.60 billion rather than $391.46 billion; its holdings are unchanged versus Q2 in any case. The filing deadline follows Rule 13f-1(a) (45 days after quarter-end) with the weekend rule that moves a Saturday deadline to the next business day; the SEC’s Form 13F FAQ lists November 16, 2026 (Monday) for the September 2026 quarter. Last updated: November 11, 2026. This article reports filings; it does not recommend any security.
Frequently asked questions
How many tracked funds had filed for Q3 2026 as of November 10, 2026? 32 of 147 tracked funds, all with parsed Q3 tables in this article.
Why do some funds show the same company as both new and exited? Because the counts are CUSIP-based. A CUSIP change creates a new row and an exited row for the same company. The "largest new" and "largest exited" columns use a ticker test to avoid presenting those pairs as genuine entries or exits.
When is the Q3 2026 13F deadline? Monday, November 16, 2026.
Why is Aquamarine Capital’s total about $144 million when the filing shows $144 thousand? Because its information table is stated in thousands of dollars. Every row implies a price about 1,000 times too low at dollar scale — Berkshire Hathaway Class A at $747 a share, for example — and multiplying by 1,000 gives ordinary market prices. The pipeline’s cover-total check cannot catch this, because the cover total is itself in thousands. The fund’s holdings are unchanged versus Q2 either way.
Why doesn’t Exxon Mobil appear as a big new buy? Because all nine funds that hold it show the same CUSIP replacement: a new CUSIP row and an exited old CUSIP row for the same shares. Netted across the nine funds, the Exxon position grew by about $21.9 million in value while the share count fell by about 1.1 million shares.
Revision history
Nov 11, 2026: First published (data as of Nov 10, 2026). Row-count criterion stated: 2,706 raw information-table rows as filed; 2,642 (CUSIP, put/call)-aggregated analysis rows. Aquamarine Capital’s total is corrected from the pipeline’s $144 thousand to about $144.26 million (filing scale: thousands of dollars).